Advanced Tumors Hinder Dendritic Cell Interstitial Motility by Deregulating cGMP
Major Finding: Dendritic cell (DC) migration to tumor-draining lymph nodes (tdLN) is markedly decreased in late-stage tumors. Concept: A PDE5/sGC-mediated imbalance of intracellular cGMP in DCs prevents optimal DC motility and persistence within tdLNs.Impact: This study suggests that targeting PDE5 with an FDA-approved inhibitor may promote DC-dependent antitumor immunity.
Publication Details
- Journal
- Cancer Discovery
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1158/2159-8290.cd-rw2025-063
- Primary Topic
- Adenosine and Purinergic Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00